Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
Tipifarnib may stop the growth of cancer cells by blocking the enzymes necessary for their
growth. Phase II trial to study the effectiveness of tipifarnib in treating older patients
who have previously untreated acute myeloid leukemia